Details
Stereochemistry | RACEMIC |
Molecular Formula | C22H35NO7 |
Molecular Weight | 425.5158 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC(=CC(OC)=C1OC)C(=O)OC(COCCC(C)C)CN2CCOCC2
InChI
InChIKey=YOKPRDAUBGOISU-UHFFFAOYSA-N
InChI=1S/C22H35NO7/c1-16(2)6-9-29-15-18(14-23-7-10-28-11-8-23)30-22(24)17-12-19(25-3)21(27-5)20(13-17)26-4/h12-13,16,18H,6-11,14-15H2,1-5H3
DescriptionCurator's Comment: https://books.google.ru/books?id=mDLYCQAAQBAJ&pg=PA135&lpg=PA135&dq=AMOPROXAN
retrieved from Toxicology of the Eye: Effects on the Eyes and Visual System from Chemicals, Drugs, Metals and Minerals, Plants, Toxins, and Venoms; Also, Systemic Side Effects from Eye med (2-Volume Set), p.135
Curator's Comment: https://books.google.ru/books?id=mDLYCQAAQBAJ&pg=PA135&lpg=PA135&dq=AMOPROXAN
retrieved from Toxicology of the Eye: Effects on the Eyes and Visual System from Chemicals, Drugs, Metals and Minerals, Plants, Toxins, and Venoms; Also, Systemic Side Effects from Eye med (2-Volume Set), p.135
Amoproxan (Mederel, Mexderel), a coronary artery dilator and anti-arrhythmic, apparently withdrawn from production, produced pellagroid skin changes and several cases of axial optic neuropathy in France.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/5437771
Unknown
Route of Administration:
Unknown
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29707
Created by
admin on Fri Dec 15 16:06:57 GMT 2023 , Edited by admin on Fri Dec 15 16:06:57 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
31473
Created by
admin on Fri Dec 15 16:06:57 GMT 2023 , Edited by admin on Fri Dec 15 16:06:57 GMT 2023
|
PRIMARY | |||
|
C72652
Created by
admin on Fri Dec 15 16:06:57 GMT 2023 , Edited by admin on Fri Dec 15 16:06:57 GMT 2023
|
PRIMARY | |||
|
27RL57FCYM
Created by
admin on Fri Dec 15 16:06:57 GMT 2023 , Edited by admin on Fri Dec 15 16:06:57 GMT 2023
|
PRIMARY | |||
|
DTXSID6048838
Created by
admin on Fri Dec 15 16:06:57 GMT 2023 , Edited by admin on Fri Dec 15 16:06:57 GMT 2023
|
PRIMARY | |||
|
100000087408
Created by
admin on Fri Dec 15 16:06:57 GMT 2023 , Edited by admin on Fri Dec 15 16:06:57 GMT 2023
|
PRIMARY | |||
|
1440271
Created by
admin on Fri Dec 15 16:06:57 GMT 2023 , Edited by admin on Fri Dec 15 16:06:57 GMT 2023
|
PRIMARY | RxNorm | ||
|
SUB05474MIG
Created by
admin on Fri Dec 15 16:06:57 GMT 2023 , Edited by admin on Fri Dec 15 16:06:57 GMT 2023
|
PRIMARY | |||
|
CHEMBL2104537
Created by
admin on Fri Dec 15 16:06:57 GMT 2023 , Edited by admin on Fri Dec 15 16:06:57 GMT 2023
|
PRIMARY | |||
|
22661-76-3
Created by
admin on Fri Dec 15 16:06:57 GMT 2023 , Edited by admin on Fri Dec 15 16:06:57 GMT 2023
|
PRIMARY | |||
|
m46
Created by
admin on Fri Dec 15 16:06:57 GMT 2023 , Edited by admin on Fri Dec 15 16:06:57 GMT 2023
|
PRIMARY | Merck Index | ||
|
2678
Created by
admin on Fri Dec 15 16:06:57 GMT 2023 , Edited by admin on Fri Dec 15 16:06:57 GMT 2023
|
PRIMARY | |||
|
27RL57FCYM
Created by
admin on Fri Dec 15 16:06:57 GMT 2023 , Edited by admin on Fri Dec 15 16:06:57 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)